BTCY - Utang jangka dawa Biotricity, Inc

Biotricity, Inc. (BTCY) develops innovative Bioflux sensors for continuous heart monitoring, utilizing AI algorithms to promptly notify medical professionals of critical failures. ARR growth is driven by the scaling of its cloud services network and the implementation of new intelligent features. The business relies on a SaaS model for ECG analysis, ensuring a stable FCF at 0.00, which is confirmed by this price chart illustrating value trends.

Long-term debt measures the total volume of obligations with a maturity of more than one year, determining the issuer's financial stability. An increase in this metric signals the raising of capital for development but elevates risk during periods of rising interest rates. By analyzing the value of a firm's long-term borrowings, an investor assesses the cost of expansion. For Biotricity, Inc. (BTCY), borrowings may fund the scaling of its B2B network. This accelerates the deployment of operating leverage through a subscription model.